Novartis Lifts FullYear Sales and Profit Outlook Amid Strong Operational Performance CNP Q1 2026 Earnings Marginal EPS Miss Amid Steady Utility Operations Elon Musks Anthropic Deal Comments Add to SpaceX Skepticism Before IPO